Cargando…

Efficacy and Safety of Pharmacoinvasive Strategy Compared to Primary Percutaneous Coronary Intervention in the Management of ST-Segment Elevation Myocardial Infarction: A Prospective Country-Wide Registry

BACKGROUND: A pharmacoinvasive reperfusion strategy is recommended for ST-elevation myocardial infarction (STEMI) patients when primary percutaneous coronary intervention (PCI) cannot be achieved in a timely fashion. This is based on a limited number of trials. The effectiveness of this strategy in...

Descripción completa

Detalles Bibliográficos
Autores principales: Zubaid, Mohammad, Khraishah, Haitham, Alahmad, Barrak, Rashed, Wafa, Ridha, Mustafa, Alenezi, Fahad, Aljarralah, Mohamad, Al-Marri, Khalid, Almutairi, Mohammad, Althalji, Khalid, Alfaddagh, Abdulhamied
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ubiquity Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7006601/
https://www.ncbi.nlm.nih.gov/pubmed/32064231
http://dx.doi.org/10.5334/aogh.2632
_version_ 1783495181096452096
author Zubaid, Mohammad
Khraishah, Haitham
Alahmad, Barrak
Rashed, Wafa
Ridha, Mustafa
Alenezi, Fahad
Aljarralah, Mohamad
Al-Marri, Khalid
Almutairi, Mohammad
Althalji, Khalid
Alfaddagh, Abdulhamied
author_facet Zubaid, Mohammad
Khraishah, Haitham
Alahmad, Barrak
Rashed, Wafa
Ridha, Mustafa
Alenezi, Fahad
Aljarralah, Mohamad
Al-Marri, Khalid
Almutairi, Mohammad
Althalji, Khalid
Alfaddagh, Abdulhamied
author_sort Zubaid, Mohammad
collection PubMed
description BACKGROUND: A pharmacoinvasive reperfusion strategy is recommended for ST-elevation myocardial infarction (STEMI) patients when primary percutaneous coronary intervention (PCI) cannot be achieved in a timely fashion. This is based on a limited number of trials. The effectiveness of this strategy in the real-world is unclear. OBJECTIVES: To compare the effectiveness of pharmacoinvasive strategy versus primary PCI using a nationwide prospective registry of STEMI patients. METHODS: We examined 936 STEMI patients from the reperfusion in ST-elevation myocardial infarction in Kuwait (REPERFUSE Kuwait) registry who underwent either primary PCI or pharmacoinvasive reperfusion. A composite outcome was measured based on death, congestive heart failure, reinfarction or stroke prospectively ascertained during hospital stay and up to one-year follow-up. The association between reperfusion strategy and the composite outcome was assessed using multivariate regression and Poisson proportional hazard model. RESULTS: Compared to the pharmacoinvasive group, those undergoing primary PCI had higher Killip class on presentation and required more blood transfusions during hospitalization. There was no significant difference between primary PCI and pharmacoinvasive strategy with regards to the incidence of the composite outcome during the in-hospital period (RR = 1.0; 95% CI 0.98–1.02; p = 0.96) after adjustment for possible confounders. Over one-year follow-up, the survival of the two groups was not different (p = 0.66). The incidence of major bleeding was similar in both groups. CONCLUSION: STEMI patients treated with a pharmacoinvasive strategy have comparable outcomes to those treated with primary PCI with no increased risk of major bleeding. These real-world data support the use of a pharmacoinvasive strategy when primary PCI cannot be achieved in a timely fashion.
format Online
Article
Text
id pubmed-7006601
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Ubiquity Press
record_format MEDLINE/PubMed
spelling pubmed-70066012020-02-14 Efficacy and Safety of Pharmacoinvasive Strategy Compared to Primary Percutaneous Coronary Intervention in the Management of ST-Segment Elevation Myocardial Infarction: A Prospective Country-Wide Registry Zubaid, Mohammad Khraishah, Haitham Alahmad, Barrak Rashed, Wafa Ridha, Mustafa Alenezi, Fahad Aljarralah, Mohamad Al-Marri, Khalid Almutairi, Mohammad Althalji, Khalid Alfaddagh, Abdulhamied Ann Glob Health Original Research BACKGROUND: A pharmacoinvasive reperfusion strategy is recommended for ST-elevation myocardial infarction (STEMI) patients when primary percutaneous coronary intervention (PCI) cannot be achieved in a timely fashion. This is based on a limited number of trials. The effectiveness of this strategy in the real-world is unclear. OBJECTIVES: To compare the effectiveness of pharmacoinvasive strategy versus primary PCI using a nationwide prospective registry of STEMI patients. METHODS: We examined 936 STEMI patients from the reperfusion in ST-elevation myocardial infarction in Kuwait (REPERFUSE Kuwait) registry who underwent either primary PCI or pharmacoinvasive reperfusion. A composite outcome was measured based on death, congestive heart failure, reinfarction or stroke prospectively ascertained during hospital stay and up to one-year follow-up. The association between reperfusion strategy and the composite outcome was assessed using multivariate regression and Poisson proportional hazard model. RESULTS: Compared to the pharmacoinvasive group, those undergoing primary PCI had higher Killip class on presentation and required more blood transfusions during hospitalization. There was no significant difference between primary PCI and pharmacoinvasive strategy with regards to the incidence of the composite outcome during the in-hospital period (RR = 1.0; 95% CI 0.98–1.02; p = 0.96) after adjustment for possible confounders. Over one-year follow-up, the survival of the two groups was not different (p = 0.66). The incidence of major bleeding was similar in both groups. CONCLUSION: STEMI patients treated with a pharmacoinvasive strategy have comparable outcomes to those treated with primary PCI with no increased risk of major bleeding. These real-world data support the use of a pharmacoinvasive strategy when primary PCI cannot be achieved in a timely fashion. Ubiquity Press 2020-02-05 /pmc/articles/PMC7006601/ /pubmed/32064231 http://dx.doi.org/10.5334/aogh.2632 Text en Copyright: © 2020 The Author(s) http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC-BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. See http://creativecommons.org/licenses/by/4.0/.
spellingShingle Original Research
Zubaid, Mohammad
Khraishah, Haitham
Alahmad, Barrak
Rashed, Wafa
Ridha, Mustafa
Alenezi, Fahad
Aljarralah, Mohamad
Al-Marri, Khalid
Almutairi, Mohammad
Althalji, Khalid
Alfaddagh, Abdulhamied
Efficacy and Safety of Pharmacoinvasive Strategy Compared to Primary Percutaneous Coronary Intervention in the Management of ST-Segment Elevation Myocardial Infarction: A Prospective Country-Wide Registry
title Efficacy and Safety of Pharmacoinvasive Strategy Compared to Primary Percutaneous Coronary Intervention in the Management of ST-Segment Elevation Myocardial Infarction: A Prospective Country-Wide Registry
title_full Efficacy and Safety of Pharmacoinvasive Strategy Compared to Primary Percutaneous Coronary Intervention in the Management of ST-Segment Elevation Myocardial Infarction: A Prospective Country-Wide Registry
title_fullStr Efficacy and Safety of Pharmacoinvasive Strategy Compared to Primary Percutaneous Coronary Intervention in the Management of ST-Segment Elevation Myocardial Infarction: A Prospective Country-Wide Registry
title_full_unstemmed Efficacy and Safety of Pharmacoinvasive Strategy Compared to Primary Percutaneous Coronary Intervention in the Management of ST-Segment Elevation Myocardial Infarction: A Prospective Country-Wide Registry
title_short Efficacy and Safety of Pharmacoinvasive Strategy Compared to Primary Percutaneous Coronary Intervention in the Management of ST-Segment Elevation Myocardial Infarction: A Prospective Country-Wide Registry
title_sort efficacy and safety of pharmacoinvasive strategy compared to primary percutaneous coronary intervention in the management of st-segment elevation myocardial infarction: a prospective country-wide registry
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7006601/
https://www.ncbi.nlm.nih.gov/pubmed/32064231
http://dx.doi.org/10.5334/aogh.2632
work_keys_str_mv AT zubaidmohammad efficacyandsafetyofpharmacoinvasivestrategycomparedtoprimarypercutaneouscoronaryinterventioninthemanagementofstsegmentelevationmyocardialinfarctionaprospectivecountrywideregistry
AT khraishahhaitham efficacyandsafetyofpharmacoinvasivestrategycomparedtoprimarypercutaneouscoronaryinterventioninthemanagementofstsegmentelevationmyocardialinfarctionaprospectivecountrywideregistry
AT alahmadbarrak efficacyandsafetyofpharmacoinvasivestrategycomparedtoprimarypercutaneouscoronaryinterventioninthemanagementofstsegmentelevationmyocardialinfarctionaprospectivecountrywideregistry
AT rashedwafa efficacyandsafetyofpharmacoinvasivestrategycomparedtoprimarypercutaneouscoronaryinterventioninthemanagementofstsegmentelevationmyocardialinfarctionaprospectivecountrywideregistry
AT ridhamustafa efficacyandsafetyofpharmacoinvasivestrategycomparedtoprimarypercutaneouscoronaryinterventioninthemanagementofstsegmentelevationmyocardialinfarctionaprospectivecountrywideregistry
AT alenezifahad efficacyandsafetyofpharmacoinvasivestrategycomparedtoprimarypercutaneouscoronaryinterventioninthemanagementofstsegmentelevationmyocardialinfarctionaprospectivecountrywideregistry
AT aljarralahmohamad efficacyandsafetyofpharmacoinvasivestrategycomparedtoprimarypercutaneouscoronaryinterventioninthemanagementofstsegmentelevationmyocardialinfarctionaprospectivecountrywideregistry
AT almarrikhalid efficacyandsafetyofpharmacoinvasivestrategycomparedtoprimarypercutaneouscoronaryinterventioninthemanagementofstsegmentelevationmyocardialinfarctionaprospectivecountrywideregistry
AT almutairimohammad efficacyandsafetyofpharmacoinvasivestrategycomparedtoprimarypercutaneouscoronaryinterventioninthemanagementofstsegmentelevationmyocardialinfarctionaprospectivecountrywideregistry
AT althaljikhalid efficacyandsafetyofpharmacoinvasivestrategycomparedtoprimarypercutaneouscoronaryinterventioninthemanagementofstsegmentelevationmyocardialinfarctionaprospectivecountrywideregistry
AT alfaddaghabdulhamied efficacyandsafetyofpharmacoinvasivestrategycomparedtoprimarypercutaneouscoronaryinterventioninthemanagementofstsegmentelevationmyocardialinfarctionaprospectivecountrywideregistry